| Product Code: ETC8859303 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market - Industry Life Cycle |
3.4 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market - Porter's Five Forces |
3.5 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.9 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.10 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of COPD in Poland |
4.2.2 Growing awareness about COPD diagnosis and treatment |
4.2.3 Technological advancements in COPD drug development |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approvals |
4.3.2 High cost associated with COPD medications |
4.3.3 Limited access to healthcare services in certain regions of Poland |
5 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Trends |
6 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market, By Types |
6.1 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Phosphodiestrase-4 Inhibitors, 2021- 2031F |
6.1.4 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Long-Acting Bronchodilators, 2021- 2031F |
6.1.5 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Short-Acting Bronchodilators, 2021- 2031F |
6.1.6 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Methylxanthines, 2021- 2031F |
6.1.7 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.2 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Inhalers, 2021- 2031F |
6.2.3 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Nebulizers, 2021- 2031F |
6.3 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market, By Type |
6.3.1 Overview and Analysis |
6.3.2 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Chronic Bronchitis, 2021- 2031F |
6.3.3 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Emphysema, 2021- 2031F |
6.4 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market, By Diagnosis |
6.4.1 Overview and Analysis |
6.4.2 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Pirometry, 2021- 2031F |
6.4.3 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Diagnostic Tests, 2021- 2031F |
6.4.4 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market, By Treatment |
6.5.1 Overview and Analysis |
6.5.2 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Oxygen Therapy, 2021- 2031F |
6.5.3 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Lung Transplant, 2021- 2031F |
6.5.4 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Drug Therapy, 2021- 2031F |
6.5.5 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Vaccination, 2021- 2031F |
6.5.6 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Surgery, 2021- 2031F |
6.5.7 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.6.3 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Home Care Settings, 2021- 2031F |
6.6.4 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Import-Export Trade Statistics |
7.1 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Export to Major Countries |
7.2 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Imports from Major Countries |
8 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Key Performance Indicators |
8.1 Number of COPD diagnoses in Poland |
8.2 Adoption rate of new COPD treatments in the market |
8.3 Rate of hospitalizations due to COPD exacerbations |
8.4 Patient adherence to COPD medication regimens |
8.5 Number of healthcare professionals specializing in COPD management |
9 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market - Opportunity Assessment |
9.1 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Opportunity Assessment, By Type, 2021 & 2031F |
9.4 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.5 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.6 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market - Competitive Landscape |
10.1 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenue Share, By Companies, 2024 |
10.2 Poland Chronic Obstructive Pulmonary Disease (COPD) Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here